Cann GroupASX:CAN 14-Day RSI is 53.47 as of Jul. 03, 2026. The stock has 7 warning signs investors should review. Among 1,049 Drug Manufacturers companies, Cann Group ranks worse than 66.92% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-03), Cann Group's 14-Day RSI is 53.47.
The industry rank for Cann Group's 14-Day RSI or its related term are showing as below:
ASX:CAN's 14-Day RSI is ranked worse than 66.92% of 1049
companies
in the Drug Manufacturers industry
Industry Median: 47.96
vs ASX:CAN: 53.47
Cann Group (ASX:CAN) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Cann Group 14-Day RSI Related Terms
ASX:CAN vs ZTS, UTHR: 14-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cann Group's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cann Group 14-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cann Group's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Cann Group's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cann Group (ASX:CAN) has a 14-Day RSI of 53.47 as of Jul. 03, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Cann Group and its competitors. According to the industry distribution chart, Cann Group ranks #702 out of 1049 companies in the Drug Manufacturers industry, placing it in the top 66.9%.
Is Cann Group's 14-Day RSI too high?
Cann Group's current 14-Day RSI is 53.47. The Drug Manufacturers industry median 14-Day RSI is 47.96. Cann Group's value of 53.47 is 11.5% above this industry median. Based on the distribution chart, Cann Group ranks #702 out of 1049 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Cann Group's 14-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cann Group ranks #702 out of 1049 companies for 14-Day RSI. This places Cann Group in the lower half of its industry. The industry median 14-Day RSI is 47.96. Cann Group's value of 53.47 is 11.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Drug Manufacturers company?
The median 14-Day RSI among Drug Manufacturers companies is 47.96, based on 1,049 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cann Group's current 14-Day RSI of 53.47 is 11.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Cann Group and its competitors. For the Drug Manufacturers industry, the median 14-Day RSI is 47.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cann Group's current 14-Day RSI is 53.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cann Group stock overvalued right now?
Based on GuruFocus' analysis, Cann Group (ASX:CAN) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 77.5% below its estimated fair value. The current 14-Day RSI is 53.47 and 11.5% above the Drug Manufacturers industry median of 47.96. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Cann Group (ASX:CAN), the current 14-Day RSI is 53.47 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CAN has been successfully added to your